Role of Exogenous Progesterone in the Treatment of Men and Women with Substance Use Disorders: A Narrative Review

CNS Drugs
MacKenzie R Peltier, Mehmet Sofuoglu

Abstract

Substance use disorders (SUDs) remain problematic as many individuals are untreated or do not benefit from the currently available interventions. Thus, there is an urgent need to develop novel pharmacological interventions to treat SUDs. Evidence suggests that the female sex hormone, progesterone, attenuates the craving for and the euphoric effects of drugs of abuse. Research to date has demonstrated that progesterone may modulate responses to drugs of abuse and may have utility as a novel treatment for SUDs. A literature search was conducted to identify and examine studies that administered exogenous progesterone. Sixteen publications were identified, exploring the utility of exogenous progesterone or its metabolite, allopregnanolone, among a range of substances, including amphetamines (one study), benzodiazepines (one study), cocaine (nine studies), and tobacco/nicotine (five studies). Results indicated that exogenous progesterone and, its metabolite allopregnanolone, demonstrated preliminary efficacy as a treatment for substance use in both men and women. Notably, progesterone appears to target negative affect and augment cognitive functioning, especially among female substance users. Additional research is needed to explore...Continue Reading

References

Feb 9, 2000·Psychopharmacology·W J Lynch, M E Carroll
Jun 23, 2001·Pharmacology, Biochemistry, and Behavior·M SofuogluD K Hatsukami
Jul 31, 2001·CNS Drugs·K A Perkins
Aug 31, 2001·Pharmacology, Biochemistry, and Behavior·W J LynchM E Carroll
Mar 20, 2002·Pharmacology, Biochemistry, and Behavior·Mehmet SofuogluDorothy K Hatsukami
Aug 15, 2002·Pharmacology, Biochemistry, and Behavior·Theodore J CiceroEdward R Meyer
Sep 6, 2002·Pharmacology, Biochemistry, and Behavior·Tara L WhiteHarriet de Wit
Jan 25, 2003·Pharmacology, Biochemistry, and Behavior·Theodore J CiceroEdward R Meyer
Apr 2, 2003·Pharmacology, Biochemistry, and Behavior·Veronica BisagnoVictoria N Luine
Jan 28, 2004·Alcoholism, Clinical and Experimental Research·Elena I Varlinskaya, Linda P Spear
Feb 12, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Wendy J Lynch, Jane R Taylor
Aug 11, 2004·Pharmacology, Biochemistry, and Behavior·Mehmet SofuogluThomas R Kosten
Nov 6, 2004·Neuroscience and Biobehavioral Reviews·Megan E RothMarilyn E Carroll
Jan 27, 2005·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·M Oettel, A K Mukhopadhyay
May 28, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lisa R JacksonJill B Becker
Sep 15, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Suzette M Evans, Richard W Foltin
Jun 15, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Chris C StreeterDeborah A Yurgelun-Todd
Aug 21, 2007·Biochemical Pharmacology·Daniel Bertrand, Murali Gopalakrishnan
Sep 14, 2007·Drug and Alcohol Dependence·Mathilde M HuskySherry A McKee
Oct 2, 2007·Frontiers in Neuroendocrinology·Jill B Becker, Ming Hu
Oct 11, 2007·Experimental and Clinical Psychopharmacology·Justin J AnkerMarilyn E Carroll
Mar 7, 2008·Journal of Women's Health·Matthew J CarpenterHimanshu P Upadhyaya
Apr 17, 2008·Addiction·Sharon S AllenDorothy Hatsukami
Mar 31, 2009·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Arthur W Blume, G Alan Marlatt
Sep 12, 2009·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·William ReillyLeslie L Devaud
Oct 13, 2009·Hormones and Behavior·Marilyn E Carroll, Justin J Anker
Oct 20, 2009·Hormones and Behavior·Nancy K Mello
Apr 14, 2010·The Psychiatric Clinics of North America·Shelly F GreenfieldKathleen T Brady
Apr 20, 2010·Hormones and Behavior·Stephanie C ReedSuzette M Evans
May 22, 2010·Neuroscience and Biobehavioral Reviews·Amanda Hudson, Jennifer A Stamp
Aug 3, 2010·Psychoneuroendocrinology·Mehmet SofuogluMarc Mooney
Oct 5, 2010·British Journal of Pharmacology·Sahruh TurkmenInga-Maj Johansson
Nov 26, 2010·Progress in Brain Research·Doodipala Samba Reddy
Dec 29, 2010·Experimental and Clinical Psychopharmacology·Wendy J Lynch, Mehmet Sofuoglu
Jan 5, 2011·Hormones and Behavior·Stephanie Collins ReedRichard W Foltin
May 21, 2011·Biochemical Pharmacology·Anshul Pandya, Jerrel L Yakel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.